HEADER TRANSCRIPTION, LIGAND BINDING PROTEIN 16-DEC-04 1Y9R TITLE CRYSTAL STRUCTURE OF THE HUMAN MINERALOCORTICOID RECEPTOR LIGAND- TITLE 2 BINDING DOMAIN BOUND TO DEOXYCORTICOSTERONE AND HARBORING THE S810L TITLE 3 MUTATION RESPONSIBLE FOR A SEVERE FORM OF HYPERTENSION COMPND MOL_ID: 1; COMPND 2 MOLECULE: MINERALOCORTICOID RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN; COMPND 5 SYNONYM: MR; NUCLEAR RECEPTOR SUBFAMILY 3, GROUP C, MEMBER 2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: UV20HL21-27; SOURCE 6 GENE: NR3C2, MCR, MLR; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21 CODON PLUS (DE3) RIL; SOURCE 10 EXPRESSION_SYSTEM_CELLULAR_LOCATION: CYTOPLASM; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PGEX; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PMRLBDL810 KEYWDS MINERALOCORTICOID RECEPTOR; STEROID RECEPTOR; NUCLEAR RECEPT; KEYWDS 2 TRANSCRIPTION REGULATION; ACTIVATING MUTATION; HYPERTENSION, KEYWDS 3 TRANSCRIPTION, LIGAND BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.FAGART,J.HUYET,G.M.PINON,M.ROCHEL,C.MAYER,M.E.RAFESTIN-OBLIN REVDAT 4 20-OCT-21 1Y9R 1 REMARK SEQADV REVDAT 3 24-FEB-09 1Y9R 1 VERSN REVDAT 2 21-JUN-05 1Y9R 1 JRNL REVDAT 1 24-MAY-05 1Y9R 0 JRNL AUTH J.FAGART,J.HUYET,G.M.PINON,M.ROCHEL,C.MAYER, JRNL AUTH 2 M.E.RAFESTIN-OBLIN JRNL TITL CRYSTAL STRUCTURE OF A MUTANT MINERALOCORTICOID RECEPTOR JRNL TITL 2 RESPONSIBLE FOR HYPERTENSION JRNL REF NAT.STRUCT.MOL.BIOL. V. 12 554 2005 JRNL REFN ISSN 1545-9993 JRNL PMID 15908963 JRNL DOI 10.1038/NSMB939 REMARK 2 REMARK 2 RESOLUTION. 1.96 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.96 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 11588348.480 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.1 REMARK 3 NUMBER OF REFLECTIONS : 40302 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.200 REMARK 3 FREE R VALUE TEST SET COUNT : 4101 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.96 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.08 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 60.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4361 REMARK 3 BIN R VALUE (WORKING SET) : 0.2890 REMARK 3 BIN FREE R VALUE : 0.3430 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 504 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3885 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 461 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.69400 REMARK 3 B22 (A**2) : 0.69400 REMARK 3 B33 (A**2) : 0.68810 REMARK 3 B12 (A**2) : 0.34710 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM SIGMAA (A) : 0.21 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.900 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.090 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.680 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.570 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.070 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.76 REMARK 3 BSOL : 250.0 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : LIGAND.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : LIGAND.TOP REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Y9R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JAN-05. REMARK 100 THE DEPOSITION ID IS D_1000031294. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 69 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM30A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979583 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40302 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.960 REMARK 200 RESOLUTION RANGE LOW (A) : 18.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.09400 REMARK 200 R SYM (I) : 0.07900 REMARK 200 FOR THE DATA SET : 6.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.4 REMARK 200 DATA REDUNDANCY IN SHELL : 1.50 REMARK 200 R MERGE FOR SHELL (I) : 0.43100 REMARK 200 R SYM FOR SHELL (I) : 0.31800 REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BEAST REMARK 200 STARTING MODEL: 3D HOMOLOGY MODEL OF THE HUMAN MINERALOCORTICOID REMARK 200 RECEPTOR LIGAND BINDING DOMAIN CONSTRUCTED USING THE REMARK 200 PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, PH 7.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 297K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 13.77533 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 27.55067 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 730 REMARK 465 SER A 731 REMARK 465 ARG A 732 REMARK 465 ALA A 733 REMARK 465 LEU A 734 REMARK 465 THR A 735 REMARK 465 PRO A 736 REMARK 465 LYS A 909 REMARK 465 ALA A 910 REMARK 465 PRO A 911 REMARK 465 ASN A 912 REMARK 465 ASN A 913 REMARK 465 SER A 914 REMARK 465 GLY A 915 REMARK 465 GLN A 916 REMARK 465 LYS A 984 REMARK 465 SER B 730 REMARK 465 SER B 731 REMARK 465 ARG B 732 REMARK 465 ALA B 733 REMARK 465 LEU B 734 REMARK 465 THR B 735 REMARK 465 PRO B 736 REMARK 465 LYS B 909 REMARK 465 ALA B 910 REMARK 465 PRO B 911 REMARK 465 ASN B 912 REMARK 465 ASN B 913 REMARK 465 SER B 914 REMARK 465 GLY B 915 REMARK 465 GLN B 916 REMARK 465 SER B 917 REMARK 465 TRP B 918 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 743 CG CD OE1 OE2 REMARK 470 TYR A 754 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A 894 CG CD OE1 OE2 REMARK 470 TYR B 754 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 TYR B 754 OH REMARK 470 HIS B 841 CG ND1 CD2 CE1 NE2 REMARK 470 MET B 959 CG SD CE REMARK 470 VAL B 971 CG1 CG2 REMARK 470 ARG B 983 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 HIS B 950 O HOH B 1110 2.11 REMARK 500 NE2 GLN A 825 O HOH A 1270 2.13 REMARK 500 O HOH B 1199 O HOH B 1234 2.14 REMARK 500 NE2 GLN B 803 O HOH B 1151 2.18 REMARK 500 OE1 GLU A 748 O HOH A 1282 2.18 REMARK 500 O HOH B 1276 O HOH B 1304 2.18 REMARK 500 O ARG B 983 O HOH B 1077 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET B 777 CG - SD - CE ANGL. DEV. = -14.6 DEGREES REMARK 500 MET B 807 CG - SD - CE ANGL. DEV. = 9.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 738 -57.79 -23.06 REMARK 500 GLU A 746 101.08 -46.46 REMARK 500 PRO A 747 153.43 -32.63 REMARK 500 GLU A 748 -140.37 -97.37 REMARK 500 SER A 757 -75.31 169.80 REMARK 500 PRO A 759 121.97 -38.57 REMARK 500 LEU A 809 -72.33 -44.58 REMARK 500 SER A 824 -9.41 79.72 REMARK 500 GLU A 837 -6.03 -49.79 REMARK 500 GLN A 842 37.39 -94.34 REMARK 500 TYR A 846 108.34 -52.05 REMARK 500 GLU A 847 -38.12 148.65 REMARK 500 LEU A 878 43.33 -104.90 REMARK 500 SER A 888 36.00 -89.78 REMARK 500 GLU A 948 45.76 -107.44 REMARK 500 SER A 949 -93.74 -57.43 REMARK 500 PRO A 957 -126.41 -62.74 REMARK 500 ALA A 958 -34.34 -131.11 REMARK 500 SER A 973 -111.10 -87.16 REMARK 500 TYR A 980 -156.48 -61.18 REMARK 500 PHE A 981 -25.46 -142.16 REMARK 500 MET B 740 25.22 -79.74 REMARK 500 VAL B 741 -54.90 -134.33 REMARK 500 GLU B 746 104.43 -41.56 REMARK 500 PRO B 747 148.02 -37.58 REMARK 500 ALA B 784 37.13 -83.52 REMARK 500 LYS B 820 -97.86 -66.19 REMARK 500 SER B 824 -33.82 78.51 REMARK 500 LEU B 833 54.24 -147.51 REMARK 500 GLU B 837 -36.44 -173.00 REMARK 500 GLN B 842 9.45 -62.74 REMARK 500 ALA B 844 27.26 47.96 REMARK 500 ALA B 951 -37.14 169.03 REMARK 500 PRO B 957 -105.05 -47.61 REMARK 500 ALA B 958 -19.96 -155.57 REMARK 500 VAL B 971 -48.69 -162.79 REMARK 500 ARG B 983 -87.51 59.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 944 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1CA A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1CA B 3001 DBREF 1Y9R A 731 984 UNP P08235 MCR_HUMAN 731 984 DBREF 1Y9R B 731 984 UNP P08235 MCR_HUMAN 731 984 SEQADV 1Y9R SER A 730 UNP P08235 CLONING ARTIFACT SEQADV 1Y9R LEU A 810 UNP P08235 SER 810 ENGINEERED MUTATION SEQADV 1Y9R ALA A 910 UNP P08235 CYS 910 ENGINEERED MUTATION SEQADV 1Y9R SER B 730 UNP P08235 CLONING ARTIFACT SEQADV 1Y9R LEU B 810 UNP P08235 SER 810 ENGINEERED MUTATION SEQADV 1Y9R ALA B 910 UNP P08235 CYS 910 ENGINEERED MUTATION SEQRES 1 A 255 SER SER ARG ALA LEU THR PRO SER PRO VAL MET VAL LEU SEQRES 2 A 255 GLU ASN ILE GLU PRO GLU ILE VAL TYR ALA GLY TYR ASP SEQRES 3 A 255 SER SER LYS PRO ASP THR ALA GLU ASN LEU LEU SER THR SEQRES 4 A 255 LEU ASN ARG LEU ALA GLY LYS GLN MET ILE GLN VAL VAL SEQRES 5 A 255 LYS TRP ALA LYS VAL LEU PRO GLY PHE LYS ASN LEU PRO SEQRES 6 A 255 LEU GLU ASP GLN ILE THR LEU ILE GLN TYR SER TRP MET SEQRES 7 A 255 CYS LEU LEU SER PHE ALA LEU SER TRP ARG SER TYR LYS SEQRES 8 A 255 HIS THR ASN SER GLN PHE LEU TYR PHE ALA PRO ASP LEU SEQRES 9 A 255 VAL PHE ASN GLU GLU LYS MET HIS GLN SER ALA MET TYR SEQRES 10 A 255 GLU LEU CYS GLN GLY MET HIS GLN ILE SER LEU GLN PHE SEQRES 11 A 255 VAL ARG LEU GLN LEU THR PHE GLU GLU TYR THR ILE MET SEQRES 12 A 255 LYS VAL LEU LEU LEU LEU SER THR ILE PRO LYS ASP GLY SEQRES 13 A 255 LEU LYS SER GLN ALA ALA PHE GLU GLU MET ARG THR ASN SEQRES 14 A 255 TYR ILE LYS GLU LEU ARG LYS MET VAL THR LYS ALA PRO SEQRES 15 A 255 ASN ASN SER GLY GLN SER TRP GLN ARG PHE TYR GLN LEU SEQRES 16 A 255 THR LYS LEU LEU ASP SER MET HIS ASP LEU VAL SER ASP SEQRES 17 A 255 LEU LEU GLU PHE CYS PHE TYR THR PHE ARG GLU SER HIS SEQRES 18 A 255 ALA LEU LYS VAL GLU PHE PRO ALA MET LEU VAL GLU ILE SEQRES 19 A 255 ILE SER ASP GLN LEU PRO LYS VAL GLU SER GLY ASN ALA SEQRES 20 A 255 LYS PRO LEU TYR PHE HIS ARG LYS SEQRES 1 B 255 SER SER ARG ALA LEU THR PRO SER PRO VAL MET VAL LEU SEQRES 2 B 255 GLU ASN ILE GLU PRO GLU ILE VAL TYR ALA GLY TYR ASP SEQRES 3 B 255 SER SER LYS PRO ASP THR ALA GLU ASN LEU LEU SER THR SEQRES 4 B 255 LEU ASN ARG LEU ALA GLY LYS GLN MET ILE GLN VAL VAL SEQRES 5 B 255 LYS TRP ALA LYS VAL LEU PRO GLY PHE LYS ASN LEU PRO SEQRES 6 B 255 LEU GLU ASP GLN ILE THR LEU ILE GLN TYR SER TRP MET SEQRES 7 B 255 CYS LEU LEU SER PHE ALA LEU SER TRP ARG SER TYR LYS SEQRES 8 B 255 HIS THR ASN SER GLN PHE LEU TYR PHE ALA PRO ASP LEU SEQRES 9 B 255 VAL PHE ASN GLU GLU LYS MET HIS GLN SER ALA MET TYR SEQRES 10 B 255 GLU LEU CYS GLN GLY MET HIS GLN ILE SER LEU GLN PHE SEQRES 11 B 255 VAL ARG LEU GLN LEU THR PHE GLU GLU TYR THR ILE MET SEQRES 12 B 255 LYS VAL LEU LEU LEU LEU SER THR ILE PRO LYS ASP GLY SEQRES 13 B 255 LEU LYS SER GLN ALA ALA PHE GLU GLU MET ARG THR ASN SEQRES 14 B 255 TYR ILE LYS GLU LEU ARG LYS MET VAL THR LYS ALA PRO SEQRES 15 B 255 ASN ASN SER GLY GLN SER TRP GLN ARG PHE TYR GLN LEU SEQRES 16 B 255 THR LYS LEU LEU ASP SER MET HIS ASP LEU VAL SER ASP SEQRES 17 B 255 LEU LEU GLU PHE CYS PHE TYR THR PHE ARG GLU SER HIS SEQRES 18 B 255 ALA LEU LYS VAL GLU PHE PRO ALA MET LEU VAL GLU ILE SEQRES 19 B 255 ILE SER ASP GLN LEU PRO LYS VAL GLU SER GLY ASN ALA SEQRES 20 B 255 LYS PRO LEU TYR PHE HIS ARG LYS HET 1CA A2001 24 HET 1CA B3001 24 HETNAM 1CA DESOXYCORTICOSTERONE HETSYN 1CA 4-PREGNEN-21-OL-3,20-DIONE; DOC; 21-HYDROXYPROGESTERONE FORMUL 3 1CA 2(C21 H30 O3) FORMUL 5 HOH *461(H2 O) HELIX 1 1 SER A 737 GLU A 746 1 10 HELIX 2 2 THR A 761 LYS A 785 1 25 HELIX 3 3 GLY A 789 LEU A 793 5 5 HELIX 4 4 PRO A 794 ASN A 823 1 30 HELIX 5 5 MET A 840 ALA A 844 5 5 HELIX 6 6 LEU A 848 GLN A 863 1 16 HELIX 7 7 THR A 865 LEU A 878 1 14 HELIX 8 8 SER A 888 THR A 908 1 21 HELIX 9 9 SER A 917 GLU A 948 1 32 HELIX 10 10 GLU A 948 LYS A 953 1 6 HELIX 11 11 LEU A 960 GLU A 972 1 13 HELIX 12 12 PRO B 738 GLU B 746 1 9 HELIX 13 13 THR B 761 ALA B 784 1 24 HELIX 14 14 GLY B 789 LEU B 793 5 5 HELIX 15 15 PRO B 794 ASN B 823 1 30 HELIX 16 16 MET B 845 GLN B 863 1 19 HELIX 17 17 THR B 865 LEU B 878 1 14 HELIX 18 18 SER B 888 VAL B 907 1 20 HELIX 19 19 GLN B 919 GLU B 948 1 30 HELIX 20 20 GLU B 948 LYS B 953 1 6 HELIX 21 21 ALA B 958 LEU B 968 1 11 HELIX 22 22 PRO B 969 VAL B 971 5 3 SHEET 1 A 2 LEU A 827 ALA A 830 0 SHEET 2 A 2 LEU A 833 PHE A 835 -1 O LEU A 833 N ALA A 830 SHEET 1 B 2 THR A 880 PRO A 882 0 SHEET 2 B 2 ALA A 976 PRO A 978 -1 O LYS A 977 N ILE A 881 SHEET 1 C 2 LEU B 827 TYR B 828 0 SHEET 2 C 2 VAL B 834 PHE B 835 -1 O PHE B 835 N LEU B 827 SHEET 1 D 2 THR B 880 PRO B 882 0 SHEET 2 D 2 ALA B 976 PRO B 978 -1 O LYS B 977 N ILE B 881 SITE 1 AC1 14 LEU A 769 ASN A 770 LEU A 772 ALA A 773 SITE 2 AC1 14 GLN A 776 MET A 807 LEU A 810 LEU A 814 SITE 3 AC1 14 ARG A 817 MET A 845 PHE A 941 CYS A 942 SITE 4 AC1 14 THR A 945 VAL A 954 SITE 1 AC2 17 LEU B 769 ASN B 770 LEU B 772 GLN B 776 SITE 2 AC2 17 MET B 807 LEU B 810 LEU B 814 ARG B 817 SITE 3 AC2 17 PHE B 829 MET B 845 MET B 852 PHE B 941 SITE 4 AC2 17 CYS B 942 THR B 945 VAL B 954 PHE B 956 SITE 5 AC2 17 HOH B1255 CRYST1 120.284 120.284 41.326 90.00 90.00 120.00 P 31 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008314 0.004800 0.000000 0.00000 SCALE2 0.000000 0.009600 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024198 0.00000 MASTER 389 0 2 22 8 0 9 6 0 0 0 40 END